Peter Smith
Direktor/Vorstandsmitglied bei RACE ONCOLOGY LIMITED
Profil
Peter M.
Smith was the founder of Onyvax Ltd.
(founded in 1996) where he held the title of Finance Director from 1996 to 2013.
He is currently the Chief Executive Officer & Director at Myrio Therapeutics Pty Ltd.
(since 2016), Executive Director at Race Oncology Ltd.
(since 2023), and Director at MycRx.
In the past, he served as the Chief Executive Officer & Managing Director at CSL Innovation Pty Ltd.
(2003-2005), Chief Executive Officer, Executive Director & MD at The Sustainable Nutrition Group Pty Ltd.
(2012-2013), President, Chief Executive Officer & Director at Audeo Oncology, Inc. (2012-2013), and Chairman & Chief Executive Officer at Cerylid Biosciences Ltd.
(2005-2006).
He also held the position of Non-Executive Chairman at Ascend Biopharmaceuticals Ltd.
Dr. Smith obtained undergraduate and doctorate degrees from the University of Cambridge.
Aktive Positionen von Peter Smith
Unternehmen | Position | Beginn |
---|---|---|
RACE ONCOLOGY LIMITED | Direktor/Vorstandsmitglied | 29.06.2023 |
Myrio Therapeutics Pty Ltd. | Vorstandsvorsitzender | 01.11.2016 |
MycRx
MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Peter Smith
Unternehmen | Position | Ende |
---|---|---|
THE SUSTAINABLE NUTRITION GROUP LTD | Vorstandsvorsitzender | 25.01.2013 |
Audeo Oncology, Inc.
Audeo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Audeo Oncology, Inc. used to provide cancer treatment services. It focused on utilizing its Hyaluronic Acid Chemotransport technology for cancer drugs and tumor cells to enhance drug activities. The company was founded on June 1, 2012 and was headquartered in San Francisco, CA. | Vorstandsvorsitzender | 25.01.2013 |
Cerylid Biosciences Ltd.
Cerylid Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Cerylid Biosciences Ltd. is an Australian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Richmond, Australia. | Vorstandsvorsitzender | 01.01.2006 |
ZENYTH THERAPEUTICS LIMITED | Vorstandsvorsitzender | - |
Ascend Biopharmaceuticals Ltd.
Ascend Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia. | Vorsitzender | - |
Ausbildung von Peter Smith
University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RACE ONCOLOGY LIMITED | Health Technology |
Private Unternehmen | 8 |
---|---|
The Sustainable Nutrition Group Pty Ltd.
The Sustainable Nutrition Group Pty Ltd. Agricultural Commodities/MillingProcess Industries The Sustainable Nutrition Group Ltd. produces, manufactures, and distributes a range of hemp products in Australia. It is involved in hemp seed selection, farming, processing, and packaging, as well as distribution and sale of bulk and retail products. The company's products include hand sanitizers, hemp oils, hemp seeds, hemp protein powders, and hemp flour under the APH and Mt Elephant brands to retail, wholesale, and white label customers. The company was founded by James Hood and Tracie Rams dale in 1995 and is headquartered in Newtown, Australia. | Process Industries |
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
Cerylid Biosciences Ltd.
Cerylid Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Cerylid Biosciences Ltd. is an Australian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Richmond, Australia. | Health Technology |
Onyvax Ltd.
Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Onyvax Ltd. developed cancer remedy therapies. The company was founded in 1995 and was headquartered in Bradford, the United Kingdom. | Commercial Services |
Audeo Oncology, Inc.
Audeo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Audeo Oncology, Inc. used to provide cancer treatment services. It focused on utilizing its Hyaluronic Acid Chemotransport technology for cancer drugs and tumor cells to enhance drug activities. The company was founded on June 1, 2012 and was headquartered in San Francisco, CA. | Health Technology |
Ascend Biopharmaceuticals Ltd.
Ascend Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia. | Health Technology |
Myrio Therapeutics Pty Ltd. | |
MycRx
MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | Commercial Services |